SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/A1E9E734096291937C9C4F6D3C564EF753C55D8968A5C9CE99C67D633C2BA6AAAD12E5044A7D860683C197BF84C78810>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/A1E9E734096291937C9C4F6D3C564EF753C55D8968A5C9CE99C67D633C2BA6AAAD12E5044A7D860683C197BF84C78810
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A1E9E734096291937C9C4F6D3C564EF753C55D8968A5C9CE99C67D633C2BA6AAAD12E5044A7D860683C197BF84C78810
http://www.w3.org/2000/01/rdf-schema#comment
"The findings implicate Aven in ATR-Chk1 signalling and point towards Chk1 inhibition as a strategy to sensitize human osteosarcomas to chemotherapy."
xsd:string
http://purl.uniprot.org/uniprot/#_5A7F87A37472DC21082AB02AEE54784976749AB0BD00D737723A4397441CD8E44E48D6F53DB46EC508C461E26165AC42
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/A1E9E734096291937C9C4F6D3C564EF753C55D8968A5C9CE99C67D633C2BA6AAAD12E5044A7D860683C197BF84C78810
http://purl.uniprot.org/uniprot/E7EPP6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A1E9E734096291937C9C4F6D3C564EF753C55D8968A5C9CE99C67D633C2BA6AAAD12E5044A7D860683C197BF84C78810
http://purl.uniprot.org/uniprot/#_E7EPP6-mappedCitation-25757065
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/A1E9E734096291937C9C4F6D3C564EF753C55D8968A5C9CE99C67D633C2BA6AAAD12E5044A7D860683C197BF84C78810